期刊
JOURNAL OF MEDICAL GENETICS
卷 58, 期 3, 页码 178-184出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/jmedgenet-2019-106498
关键词
genetics; diagnostics; imprinting; clinical genetics; epigenetics
资金
- National Institute of Health [K08 CA193915]
- Alex's Lemonade Stand Foundation
- St Baldrick's Foundation
Beckwith-Wiedemann Syndrome (BWS) is characterized by overgrowth and tumor predisposition, mainly caused by methylation defects in imprinting control regions on chromosome 11p15.5. Molecular diagnosis of BWS requires the use of multiple sensitive diagnostic techniques to reliably detect low-level aberrations. Testing both blood and solid tissue samples can increase the diagnostic yield and identify mosaic disease among individuals with BWSp.
Background Beckwith-Wiedemann Syndrome (BWS) is characterised by overgrowth and tumour predisposition. While multiple epigenetic and genetic mechanisms cause BWS, the majority are caused by methylation defects in imprinting control regions on chromosome 11p15.5. Disease-causing methylation defects are often mosaic within affected individuals. Phenotypic variability among individuals with chromosome 11p15.5 defects and tissue mosaicism led to the definition of the Beckwith-Wiedemann Spectrum (BWSp). Molecular diagnosis of BWSp requires use of multiple sensitive diagnostic techniques to reliably detect low-level aberrations. Methods Multimodal BWS diagnostic testing was performed on samples from 1057 individuals. Testing included use of a sensitive qRT-PCR-based quantitation method enabling identification of low-level mosaic disease, identification of CNVs within 11p15.5 via array comparative genomic hybridisation or qRT-PCR, and Sanger sequencing of CDKN1C. Results A molecular diagnosis was confirmed for 27.4% of individuals tested, of whom 43.4% had mosaic disease. The presence of a single cardinal feature was associated with a molecular diagnosis of BWSp in 20% of cases. Additionally, significant differences in the prevalence of mosaic disease among BWS molecular subtypes were identified. Finally, the diagnostic yield obtained by testing solid tissue samples from individuals with negative blood testing results shows improved molecular diagnosis. Conclusion This study highlights the prevalence of mosaic disease among individuals with BWSp and the increases in diagnostic yield obtained via testing both blood and solid tissue samples from affected individuals. Additionally, the results establish the presence of a molecular diagnosis in individuals with very subtle features of BWSp.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据